Kenneth Quinto

Kenneth Quinto is currently the Executive Director at Eli Lilly, specializing in neuroscience clinical design and pragmatic trials. They previously held positions as a Medical Officer at the FDA, where they focused on real-world evidence and policy development, and served as an Epidemic Intelligence Service Officer at the CDC. Kenneth completed their medical education with a Doctor of Medicine from the University of California, San Francisco, and holds a Master of Public Health in Epidemiology from the University of California, Berkeley, along with a Bachelor's degree in Biology from UCLA. Their extensive experience in public health and clinical research spans various roles in esteemed organizations.